Abstract
Abstract
Background
Research into Alzheimer’s disease and other dementias increasingly involves large-scale data-sharing initiatives. The development of novel digital tools and assessments is likely to increase the need for these. This presents ethics and governance challenges to ensure the use of these data is able to maximise the benefit to patients and the public.
Discussion
We consider the challenges associated with informed consent and governance in the context of dementia research. We set out the potential of novel data governance approaches for the future of data sharing for dementia.
Summary
The data trust model proposed in discussions of data governance may have potentially valuable application for dementia research. Such inclusive approaches to trustworthy data governance should be considered as data-sharing initiatives are established and develop.
Funder
Wellcome Trust
Medical Research Council
National Institute for Health Research
Publisher
Springer Science and Business Media LLC
Subject
Cognitive Neuroscience,Clinical Neurology,Neurology
Reference20 articles.
1. OECD. Unleashing the power of big data for Alzheimer’s disease and dementia research March 2014. doi:https://doi.org/10.1787/5jz73kvmvbwb-en.
2. Kourtis LC, Regele OB, Wright JM, Jones GB. Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity. NPJ Digit Med. 2019;2(1):9. https://doi.org/10.1038/s41746-019-0084-2.
3. Davies S. Annual report of the chief medical office, 2018: health 2040 - better health within reach. London; 2018.
4. National Academies of Sciences and Medicine E. Harnessing mobile devices for nervous system disorders: proceedings of a workshop. Washington, D.C.: The National Academies Press; 2018.
5. Ipsos MORI. The one-way mirror: public attitudes to commercial access to health data. London: The Wellcome Trust; 2016.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献